Clinical Trial Update: Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing oxandrolone to megestrol for preventing weight loss in cancer patients undergoing chemotherapy; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Oxandrolone (Oxandrolone)
• megestrol (megestrol)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Unspecified Adult Solid Tumor, Protocol Specific, Weight Changes | Phase 3 | Status: COMPLETED